Skip to content

DaVita DVA Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Operating margin15.1%-0.7pp15%-1.3pp15.4%+0.3pp15.8%+0.8pp15.8%+1.4pp
Net margin5.6%-1.0pp5.5%-1.8pp5.8%-0.7pp6.4%-0.5pp6.6%0.0pp
EBITDA margin20.3%-1.0pp20.2%-1.7pp20.7%-0.3pp21.2%+0.3pp21.3%+0.8pp
Free cash flow margin10.8%-2.8pp9.6%-1.8pp9.7%-1.5pp9.8%-0.3pp13.6%+6.1pp
Returns
Return on assets4.5%-0.5pp4.3%-1.2pp4.4%-0.4pp4.8%-0.2pp5%+0.2pp
Return on invested capital13.9%+0.1pp13.6%-0.7pp14.1%+1.0pp13.7%+1.3pp13.8%+2.0pp
Efficiency
Asset turnover0.8×0.0×0.8×0.0×0.8×0.0×0.8×0.0×0.8×0.0×
Liquidity
Current ratio1.4×+0.2×1.3×0.0×1.4×0.0×1.4×+0.2×1.3×-0.2×
Quick ratio1.4×+0.2×1.2×0.0×1.3×0.0×1.3×+0.2×1.2×-0.2×
Cash ratio0.3×+0.1×0.2×-0.1×0.3×-0.1×0.3×+0.1×0.2×0.0×
Leverage
Debt-to-assets0.8×0.0×0.8×0.0×0.7×0.0×0.7×0.0×0.7×0.0×
Net debt / EBITDA4.5×+0.2×4.5×+0.4×4.4×+0.1×4.4×-0.1×4.3×-0.2×
Interest coverage3.5×-0.5×3.5×-0.9×3.6×-0.9×3.7×-1.0×-0.4×
Per Share
Book value per share-$10.97-234%-$8.58-718%-$7.75-272%-$4.78-167%-$3.29-132%
Valuation
Market capitalization$10.27B-16.0%$8.02B-34.6%$9.5B-30.9%$10.65B-12.3%$12.24B+1.5%
Enterprise value$22.88B-5.5%$20.43B-14.7%$21.55B-14.1%$22.85B-4.2%$24.21B+2.6%
Price / earnings13.1×-1.1×10.7×-2.4×12.3×-4.3×12.7×-1.4×14.2×-0.5×
Price / sales0.7×-0.2×0.6×-0.4×0.7×-0.4×0.8×-0.2×0.9×0.0×
EV / EBITDA8.2×-0.6×7.4×-1.1×7.8×-1.6×8.2×-0.9×8.8×-0.6×
EV / sales1.7×-0.2×1.5×-0.4×1.6×-0.4×1.7×-0.2×1.9×0.0×
Free cash flow yield14.5%+0.2pp16.3%+4.4pp13.6%+3.3pp12.1%+1.7pp14.4%+6.7pp
Earnings yield7.6%+0.6pp9.3%+1.7pp8.1%+2.1pp7.9%+0.8pp7%+0.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do DaVita's ratios come from?
Every ratio is computed from DaVita's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.